Much needed and up to date review by the Mantzoros group at Harvard Medical School of all anti obesity medications in phase II-III clinical trials. Very useful in understanding the competitive landscape, the promising future solutions for a major public health problem and importantly what makes certain compounds fail to advance. A field of major medical and market importance. Our recently published systematic review summarizing all phase 2 & 3 anti-obesity medications is #OpenAccess ! Link to the full-text publication: https://lnkd.in/dMz5B9QF Accompanied by an editorial: https://lnkd.in/dU9mJXmW #Obesity #Management #ClinicalTrials #Drugs #SystematicReview
Outstanding Christos!
Awesome!
Very Helpful
Congratulations Christos Mantzoros MD DSc PhD h.c. mult. Great work!
Congrats
Christos Mantzoros MD DSc PhD h.c. mult. Very insightful, Christos!
Accomplished Biopharmaceutical R&D Scientist, Drug Developer and Executive
4moInteresting and helpful